The release of cisplatin from mesoporous materials

碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 95 === There is an increasing interest in optimizing the efficacy of drug activity by using rationally designed and prepared drug carrier materials, and many efforts have recently been devoted to design and prepare sustained and controlled drug-release systems. Amorph...

Full description

Bibliographic Details
Main Authors: Wei-Chun Chen, 陳韋均
Other Authors: Hsiu-Mei Lin
Format: Others
Language:zh-TW
Published: 2007
Online Access:http://ndltd.ncl.edu.tw/handle/84375349332064000825
id ndltd-TW-095NTOU5111008
record_format oai_dc
spelling ndltd-TW-095NTOU51110082015-10-13T11:31:39Z http://ndltd.ncl.edu.tw/handle/84375349332064000825 The release of cisplatin from mesoporous materials 中孔洞材料的cisplatin藥物釋放 Wei-Chun Chen 陳韋均 碩士 國立臺灣海洋大學 生物科技研究所 95 There is an increasing interest in optimizing the efficacy of drug activity by using rationally designed and prepared drug carrier materials, and many efforts have recently been devoted to design and prepare sustained and controlled drug-release systems. Amorphous colloidal and porous silica are used as adjuvants in pharmaceutical technology. The advantages of using silica species as a drug carrier system are their nontoxic nature, high stability, and good biocompatibility. Mesoporous silica materials, MCM-41 and SBA-15 have attracted much attention, owing to their novel properties, such as large surface area, highly regular and unique tunable nanometer pore sizes, and tailorable surface chemical properties, which qualify them as very promising candidates for multifunctional drug carriers. Cisplatin, a drug which could suppress cell histiocytosis, is also a kind of antineoplastic agent. We use MCM-41 or SBA as drug carrier for cisplatin .In Stimulated stomach pH 1.2 solution, We confirmed that cisplatin in mesoporous materials would pass stomach entirely . Moreover, MBT-2 cell uptake cisplatin by endocytosis pathway, and the uptake maximum appear in 5 hours. Hsiu-Mei Lin 林秀美 2007 學位論文 ; thesis 87 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 95 === There is an increasing interest in optimizing the efficacy of drug activity by using rationally designed and prepared drug carrier materials, and many efforts have recently been devoted to design and prepare sustained and controlled drug-release systems. Amorphous colloidal and porous silica are used as adjuvants in pharmaceutical technology. The advantages of using silica species as a drug carrier system are their nontoxic nature, high stability, and good biocompatibility. Mesoporous silica materials, MCM-41 and SBA-15 have attracted much attention, owing to their novel properties, such as large surface area, highly regular and unique tunable nanometer pore sizes, and tailorable surface chemical properties, which qualify them as very promising candidates for multifunctional drug carriers. Cisplatin, a drug which could suppress cell histiocytosis, is also a kind of antineoplastic agent. We use MCM-41 or SBA as drug carrier for cisplatin .In Stimulated stomach pH 1.2 solution, We confirmed that cisplatin in mesoporous materials would pass stomach entirely . Moreover, MBT-2 cell uptake cisplatin by endocytosis pathway, and the uptake maximum appear in 5 hours.
author2 Hsiu-Mei Lin
author_facet Hsiu-Mei Lin
Wei-Chun Chen
陳韋均
author Wei-Chun Chen
陳韋均
spellingShingle Wei-Chun Chen
陳韋均
The release of cisplatin from mesoporous materials
author_sort Wei-Chun Chen
title The release of cisplatin from mesoporous materials
title_short The release of cisplatin from mesoporous materials
title_full The release of cisplatin from mesoporous materials
title_fullStr The release of cisplatin from mesoporous materials
title_full_unstemmed The release of cisplatin from mesoporous materials
title_sort release of cisplatin from mesoporous materials
publishDate 2007
url http://ndltd.ncl.edu.tw/handle/84375349332064000825
work_keys_str_mv AT weichunchen thereleaseofcisplatinfrommesoporousmaterials
AT chénwéijūn thereleaseofcisplatinfrommesoporousmaterials
AT weichunchen zhōngkǒngdòngcáiliàodecisplatinyàowùshìfàng
AT chénwéijūn zhōngkǒngdòngcáiliàodecisplatinyàowùshìfàng
AT weichunchen releaseofcisplatinfrommesoporousmaterials
AT chénwéijūn releaseofcisplatinfrommesoporousmaterials
_version_ 1716845387912839168